Sek Ying Chair, Doris SF Yu, Michael Timothy Ng, Qun Wang, Ho Yu Cheng, Eliza ML Wong, Janet WH Sit. Evolvement of left ventricular assist device: the implications on heart failure management[J]. Journal of Geriatric Cardiology, 2016, 13(5): 425-430. DOI: 10.11909/j.issn.1671-5411.2016.05.015
Citation: Sek Ying Chair, Doris SF Yu, Michael Timothy Ng, Qun Wang, Ho Yu Cheng, Eliza ML Wong, Janet WH Sit. Evolvement of left ventricular assist device: the implications on heart failure management[J]. Journal of Geriatric Cardiology, 2016, 13(5): 425-430. DOI: 10.11909/j.issn.1671-5411.2016.05.015

Evolvement of left ventricular assist device: the implications on heart failure management

  • Heart failure (HF) is a potentially fatal disease that affects increasing number of people worldwide. Although heart transplant is the “gold standard” therapy for HF, due to the limited availability of organs, many patients died when waiting for the transplant. Left ventricular assist device (LVAD), as a mechanical circulatory support, has become a new light for patients with HF. With the technical advancements, LVADs work not only as a bridge to transplant, but also assist heart recovery and even as a destination therapy in long-term treatment. This observation paper reviewed the development of LVAD and its clinical roles. The challenges and possible solutions in nursing care for patients with LVAD at different stage of implantation were discussed. The healthcare professionals could obtain a better understanding about the LVAD treatment for HF patients.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return